{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:49:59Z","timestamp":1788922199471,"version":"build-2803163510"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-12761-6","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T14:47:23Z","timestamp":1755182843000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unveiling the therapeutic potential of octreotide in treating morphine dependence"],"prefix":"10.1038","volume":"15","author":[{"given":"Mohammad","family":"Shabani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynab","family":"Pirmoradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moazamehosadat","family":"Razavinasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Hassanshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhaneh","family":"Naderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Esmaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Navid","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Ilaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amin","family":"Langarizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossain","family":"Moqaddari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leili","family":"Rouhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meysam","family":"Ahmadi-Zeidabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi A.","family":"Kohlmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Forootanfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Banazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"12761_CR1","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/s41398-021-01542-0","volume":"11","author":"J Cheron","year":"2021","unstructured":"Cheron, J. & Kerchove d\u2019Exaerde, A. Drug addiction: from bench to bedside.Transl. Psychiatry. 11, 424 https:\/\/doi.org\/10.1038\/s41398-021-01542-0 (2021).","journal-title":"Transl. Psychiatry"},{"key":"12761_CR2","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nrn3119","volume":"12","author":"RZ Goldstein","year":"2011","unstructured":"Goldstein, R. Z. & Volkow, N. D. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat. Rev. Neurosci. 12, 652\u2013669. https:\/\/doi.org\/10.1038\/nrn3119 (2011).","journal-title":"Nat. Rev. Neurosci."},{"key":"12761_CR3","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/nn1579","volume":"8","author":"BJ Everitt","year":"2005","unstructured":"Everitt, B. J. & Robbins, T. W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 8, 1481\u20131489. https:\/\/doi.org\/10.1038\/nn1579 (2005).","journal-title":"Nat. Neurosci."},{"key":"12761_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-pharmtox-010611-134625","volume":"52","author":"ND Volkow","year":"2012","unstructured":"Volkow, N. D., Wang, G. J., Fowler, J. S. & Tomasi, D. Addiction circuitry in the human brain. Annu. Rev. Pharmacol. Toxicol. 52, 321\u2013336. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010611-134625 (2012).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"12761_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/s0893-133x(00)00195-0","volume":"24","author":"GF Koob","year":"2001","unstructured":"Koob, G. F. & Le Moal, M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24, 97\u2013129. https:\/\/doi.org\/10.1016\/s0893-133x(00)00195-0 (2001).","journal-title":"Neuropsychopharmacology"},{"key":"12761_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pbb.2019.01.007","volume":"179","author":"M Kohno","year":"2019","unstructured":"Kohno, M. et al. Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies. Pharmacol. Biochem. Behav. 179, 34\u201342 (2019).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"12761_CR7","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.drudis.2019.07.009","volume":"25","author":"T Xiaoshan","year":"2020","unstructured":"Xiaoshan, T. et al. Immunotherapy for treating methamphetamine, heroin and cocaine use disorders. Drug Discov. Today. 25, 610\u2013619 (2020).","journal-title":"Drug Discov. Today"},{"key":"12761_CR8","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3390\/antiox9090830","volume":"9","author":"P Berr\u00edos-C\u00e1rcamo","year":"2020","unstructured":"Berr\u00edos-C\u00e1rcamo, P. et al. Oxidative stress and neuroinflammation as a Pivot in drug abuse. A focus on the therapeutic potential of antioxidant and anti-inflammatory agents and biomolecules. Antioxidants. 9, 830 (2020).","journal-title":"Antioxidants"},{"key":"12761_CR9","doi-asserted-by":"publisher","first-page":"6325","DOI":"10.1073\/pnas.1200130109","volume":"109","author":"X Wang","year":"2012","unstructured":"Wang, X. et al. Morphine activates neuroinflammation in a manner parallel to endotoxin. Proc. Natl. Acad. Sci. U. S. A. 109, 6325\u20136330. https:\/\/doi.org\/10.1073\/pnas.1200130109 (2012).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"12761_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.tins.2010.02.002","volume":"33","author":"SJ Russo","year":"2010","unstructured":"Russo, S. J. et al. The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens. Trends Neurosci. 33, 267\u2013276. https:\/\/doi.org\/10.1016\/j.tins.2010.02.002 (2010).","journal-title":"Trends Neurosci."},{"key":"12761_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1460-9568.2008.06321.x","volume":"28","author":"MR Hutchinson","year":"2008","unstructured":"Hutchinson, M. R. et al. Non-stereoselective reversal of neuropathic pain by Naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4). Eur. J. Neurosci. 28, 20\u201329. https:\/\/doi.org\/10.1111\/j.1460-9568.2008.06321.x (2008).","journal-title":"Eur. J. Neurosci."},{"key":"12761_CR12","doi-asserted-by":"crossref","unstructured":"Kumar, U. & Grant, M. Somatostatin and somatostatin receptors. Cell. Pept. Hormone Synth. Secret. Pathways. 97\u2013120 (2010).","DOI":"10.1007\/400_2009_29"},{"key":"12761_CR13","doi-asserted-by":"crossref","unstructured":"Murphy, E., Prommer, E. E., Mihalyo, M. &  Wilcock, A. Octreotide. J. Pain Sympt. Manag. 40, 142\u2013148 (2010).","DOI":"10.1016\/j.jpainsymman.2010.05.002"},{"key":"12761_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1586\/17446651.2.2.129","volume":"2","author":"R Cozzi","year":"2007","unstructured":"Cozzi, R. & Attanasio, R. Octreotide for acromegaly. Expert Rev. Endocrinol. Metab. 2, 129\u2013145 (2007).","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"12761_CR15","doi-asserted-by":"publisher","first-page":"9192","DOI":"10.12998\/wjcc.v10.i26.9192","volume":"10","author":"A Khedr","year":"2022","unstructured":"Khedr, A. et al. Role of octreotide in small bowel bleeding. World J. Clin. Cases. 10, 9192 (2022).","journal-title":"World J. Clin. Cases"},{"key":"12761_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MPG.0000000000003294","volume":"74","author":"E Mas","year":"2022","unstructured":"Mas, E. et al. Drugs in focus: octreotide use in children with gastrointestinal disorders. J. Pediatr. Gastroenterol. Nutr. 74, 1\u20136 (2022).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"12761_CR17","doi-asserted-by":"crossref","unstructured":"La Salvia, A. et al. Targeting neuroendocrine tumors with octreotide and lanreotide: key points for clinical practice from NET specialists. Cancer Treat. Rev. 102560 (2023).","DOI":"10.1016\/j.ctrv.2023.102560"},{"key":"12761_CR18","doi-asserted-by":"crossref","unstructured":"Fan, M., Huang, Y., Zhu, X., Zheng, J. & Du, M. Octreotide and Octreotide-derived delivery systems. J. Drug Target. 1\u201328 (2023).","DOI":"10.1080\/1061186X.2023.2216895"},{"key":"12761_CR19","doi-asserted-by":"publisher","first-page":"e360408","DOI":"10.1590\/acb360408","volume":"36","author":"R Jiang","year":"2021","unstructured":"Jiang, R. & Wei, H. Beneficial effects of octreotide in alcohol-induced neuropathic pain. Role of H 2S, BDNF, TNF-\u03b1 and Nrf2. Acta Cir. Bras. 36, e360408. https:\/\/doi.org\/10.1590\/acb360408 (2021).","journal-title":"Acta Cir. Bras."},{"key":"12761_CR20","doi-asserted-by":"publisher","first-page":"115975","DOI":"10.1016\/j.taap.2022.115975","volume":"442","author":"SF Zou","year":"2022","unstructured":"Zou, S. F. et al. Octreotide ameliorates hepatic ischemia-reperfusion injury through SNHG12\/TAF15-mediated Sirt1 stabilization and YAP1 transcription. Toxicol. Appl. Pharmacol. 442, 115975. https:\/\/doi.org\/10.1016\/j.taap.2022.115975 (2022).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"12761_CR21","doi-asserted-by":"publisher","first-page":"115340","DOI":"10.1016\/j.taap.2020.115340","volume":"410","author":"AEE El-Sisi","year":"2021","unstructured":"El-Sisi, A. E. E., Sokar, S. S., Shebl, A. M., Mohamed, D. Z. & Abu-Risha, S. E. Octreotide and melatonin alleviate inflammasome-induced pyroptosis through Inhibition of TLR4-NF-\u03baB-NLRP3 pathway in hepatic ischemia\/reperfusion injury. Toxicol. Appl. Pharmacol. 410, 115340. https:\/\/doi.org\/10.1016\/j.taap.2020.115340 (2021).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"12761_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/21655979.2021.2012908","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang, S., Tang, C. & Wang, X. Octreotide activates autophagy to alleviate lipopolysaccharide-induced human pulmonary epithelial cell injury by inhibiting the protein kinase B (AKT)\/mammalian target of Rapamycin (mTOR) signaling pathway. Bioengineered. 13, 217\u2013226. https:\/\/doi.org\/10.1080\/21655979.2021.2012908 (2022).","journal-title":"Bioengineered"},{"key":"12761_CR23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.yfrne.2013.07.005","volume":"34","author":"M Theodoropoulou","year":"2013","unstructured":"Theodoropoulou, M. & Stalla, G. K. Somatostatin receptors: from signaling to clinical practice. Front. Neuroendocrinol. 34, 228\u2013252. https:\/\/doi.org\/10.1016\/j.yfrne.2013.07.005 (2013).","journal-title":"Front. Neuroendocrinol."},{"key":"12761_CR24","doi-asserted-by":"publisher","first-page":"16088","DOI":"10.1523\/jneurosci.1284-13.2013","volume":"33","author":"D Ferguson","year":"2013","unstructured":"Ferguson, D. et al. Essential role of SIRT1 signaling in the nucleus accumbens in cocaine and morphine action. J. Neurosci. 33, 16088\u201316098. https:\/\/doi.org\/10.1523\/jneurosci.1284-13.2013 (2013).","journal-title":"J. Neurosci."},{"key":"12761_CR25","doi-asserted-by":"publisher","first-page":"135599","DOI":"10.1016\/j.neulet.2020.135599","volume":"744","author":"L Wei","year":"2021","unstructured":"Wei, L. et al. Sirtuin 1 inhibitor EX527 suppresses morphine-induced behavioral sensitization. Neurosci. Lett. 744, 135599. https:\/\/doi.org\/10.1016\/j.neulet.2020.135599 (2021).","journal-title":"Neurosci. Lett."},{"key":"12761_CR26","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.12659\/msm.910550","volume":"24","author":"B Xia","year":"2018","unstructured":"Xia, B. et al. Effect of Sirtuin-1 on synaptic plasticity in nucleus accumbens in a rat model of heroin addiction. Med. Sci. Monit. 24, 3789\u20133803. https:\/\/doi.org\/10.12659\/msm.910550 (2018).","journal-title":"Med. Sci. Monit."},{"key":"12761_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.brainres.2014.10.058","volume":"1628","author":"JM Barker","year":"2015","unstructured":"Barker, J. M., Taylor, J. R., De Vries, T. J. & Peters, J. Brain-derived neurotrophic factor and addiction: pathological versus therapeutic effects on drug seeking. Brain Res. 1628, 68\u201381. https:\/\/doi.org\/10.1016\/j.brainres.2014.10.058 (2015).","journal-title":"Brain Res."},{"key":"12761_CR28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/164_2022_586","volume":"276","author":"J Liu","year":"2022","unstructured":"Liu, J., Li, J. X. &  Wu, R. Toll-like receptor 4: A novel target to tackle drug addiction?? Handb. Exp. Pharmacol. 276, 275\u2013290. https:\/\/doi.org\/10.1007\/164_2022_586 (2022).","journal-title":"Handb. Exp. Pharmacol."},{"key":"12761_CR29","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1177\/0269881120944159","volume":"34","author":"M Ucha","year":"2020","unstructured":"Ucha, M., Roura-Mart\u00ednez, D., Ambrosio, E. & Higuera-Matas, A. The role of the mTOR pathway in models of drug-induced reward and the behavioural constituents of addiction. J. Psychopharmacol. 34, 1176\u20131199. https:\/\/doi.org\/10.1177\/0269881120944159 (2020).","journal-title":"J. Psychopharmacol."},{"key":"12761_CR30","doi-asserted-by":"publisher","first-page":"107983","DOI":"10.1016\/j.neuropharm.2020.107983","volume":"167","author":"SL Robinson","year":"2020","unstructured":"Robinson, S. L. & Thiele, T. E. A role for the neuropeptide somatostatin in the neurobiology of behaviors associated with substances abuse and affective disorders. Neuropharmacology. 167, 107983. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.107983 (2020).","journal-title":"Neuropharmacology"},{"key":"12761_CR31","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/s0896-6273(03)00538-5","volume":"39","author":"B Lu","year":"2003","unstructured":"Lu, B. Pro-region of neurotrophins: role in synaptic modulation. Neuron. 39, 735\u2013738. https:\/\/doi.org\/10.1016\/s0896-6273(03)00538-5 (2003).","journal-title":"Neuron"},{"key":"12761_CR32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.brainres.2012.07.052","volume":"1475","author":"L Chen","year":"2012","unstructured":"Chen, L. et al. The protection by octreotide against experimental ischemic stroke: up-regulated transcription factor Nrf2, HO-1 and down-regulated NF-\u03baB expression. Brain Res. 1475, 80\u201387. https:\/\/doi.org\/10.1016\/j.brainres.2012.07.052 (2012).","journal-title":"Brain Res."},{"key":"12761_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00210-016-1303-x","volume":"390","author":"MY Al-Shorbagy","year":"2017","unstructured":"Al-Shorbagy, M. Y. & Nassar, N. N. Octreotide ameliorates inflammation and apoptosis in acute and kindled murine PTZ paradigms. Naunyn Schmiedebergs Arch. Pharmacol. 390, 61\u201368. https:\/\/doi.org\/10.1007\/s00210-016-1303-x (2017).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"12761_CR34","doi-asserted-by":"publisher","first-page":"102320","DOI":"10.1016\/j.jchemneu.2023.102320","volume":"132","author":"TK Shayan","year":"2023","unstructured":"Shayan, T. K., Abdolmaleki, A., Asadi, A. & Hassanpour, H. Neuroprotective anticonvulsant and anxiolytic effects of octreotide in Wistar rats. J. Chem. Neuroanat. 132, 102320. https:\/\/doi.org\/10.1016\/j.jchemneu.2023.102320 (2023).","journal-title":"J. Chem. Neuroanat."},{"key":"12761_CR35","doi-asserted-by":"crossref","unstructured":"Dundar, S. et al. The effects of octreotide acetate on spinal cord ischemia\/reperfusion injury. Neurosurg. Q. 25 (2015).","DOI":"10.1097\/WNQ.0000000000000109"},{"key":"12761_CR36","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3233\/jad-2009-1165","volume":"18","author":"GS Watson","year":"2009","unstructured":"Watson, G. S. et al. Effects of insulin and octreotide on memory and growth hormone in alzheimer\u2019s disease. J. Alzheimers Dis. 18, 595\u2013602. https:\/\/doi.org\/10.3233\/jad-2009-1165 (2009).","journal-title":"J. Alzheimers Dis."},{"key":"12761_CR37","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/0006-8993(91)90823-e","volume":"553","author":"N Matsuoka","year":"1991","unstructured":"Matsuoka, N., Kaneko, S. & Satoh, M. Somatostatin augments long-term potentiation of the mossy fiber-CA3 system in guinea-pig hippocampal slices. Brain Res. 553, 188\u2013194. https:\/\/doi.org\/10.1016\/0006-8993(91)90823-e (1991).","journal-title":"Brain Res."},{"key":"12761_CR38","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.cell.2007.08.002","volume":"130","author":"HM Kim","year":"2007","unstructured":"Kim, H. M. et al. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell. 130, 906\u2013917 (2007).","journal-title":"Cell"},{"key":"12761_CR39","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jmb.2012.08.002","volume":"423","author":"T Bertrand","year":"2012","unstructured":"Bertrand, T. et al. The crystal structures of TrkA and TrkB suggest key regions for achieving selective inhibition. J. Mol. Biol. 423, 439\u2013453 (2012).","journal-title":"J. Mol. Biol."},{"key":"12761_CR40","doi-asserted-by":"publisher","first-page":"109260","DOI":"10.1016\/j.neuropharm.2022.109260","volume":"220","author":"SY Lim","year":"2022","unstructured":"Lim, S. Y. (ed Cengiz, P.) Opioid tolerance and opioid-induced hyperalgesia: is TrkB modulation a potential Pharmacological solution? Neuropharmacology. 220 109260 https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109260 (2022).","journal-title":"Neuropharmacology"},{"key":"12761_CR41","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/S1097-2765(02)00550-6","volume":"9","author":"J Yang","year":"2002","unstructured":"Yang, J. et al. Molecular mechanism for the regulation of protein kinase b\/akt by hydrophobic motif phosphorylation. Mol. Cell. 9, 1227\u20131240 (2002).","journal-title":"Mol. Cell"},{"key":"12761_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep17298","volume":"5","author":"M Kashyap","year":"2015","unstructured":"Kashyap, M., Ganguly, A. K. & Bhavesh, N. S. Structural delineation of stem-loop RNA binding by human TAF15 protein. Sci. Rep. 5, 1\u201314 (2015).","journal-title":"Sci. Rep."},{"key":"12761_CR43","doi-asserted-by":"publisher","first-page":"173535","DOI":"10.1016\/j.pbb.2023.173535","volume":"224","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Opioid induces increased DNA damage in prefrontal cortex and nucleus accumbens. Pharmacol. Biochem. Behav. 224, 173535. https:\/\/doi.org\/10.1016\/j.pbb.2023.173535 (2023).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"12761_CR44","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.18632\/oncotarget.27663","volume":"11","author":"AK Singh","year":"2020","unstructured":"Singh, A. K., Kapoor, V., Thotala, D. & Hallahan, D. E. TAF15 contributes to the radiation-inducible stress response in cancer. Oncotarget. 11, 2647\u20132659. https:\/\/doi.org\/10.18632\/oncotarget.27663 (2020).","journal-title":"Oncotarget"},{"key":"12761_CR45","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000111501","volume":"87","author":"S Grozinsky-Glasberg","year":"2008","unstructured":"Grozinsky-Glasberg, S. et al. Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell line. Neuroendocrinology. 87, 168\u2013181. https:\/\/doi.org\/10.1159\/000111501 (2008).","journal-title":"Neuroendocrinology"},{"key":"12761_CR46","doi-asserted-by":"crossref","unstructured":"Bittner, E. A. & Martyn, J. A. J. In Pharmacology and Physiology for Anesthesia, 2nd edn (eds Hugh C. Hemmings & Talmage D. Egan) 412\u2013427 (Elsevier, 2019).","DOI":"10.1016\/B978-0-323-48110-6.00021-1"},{"key":"12761_CR47","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1186\/s12935-021-02334-8","volume":"21","author":"X Liu","year":"2021","unstructured":"Liu, X. et al. Morphine promotes the malignant biological behavior of non-small cell lung cancer cells through the mor\/src\/mtor pathway. Cancer Cell Int. 21, 622. https:\/\/doi.org\/10.1186\/s12935-021-02334-8 (2021).","journal-title":"Cancer Cell Int."},{"key":"12761_CR48","doi-asserted-by":"publisher","unstructured":"Gabr, M. M. et al. Interaction of opioids with TLR4-Mechanisms and ramifications. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13215274 (2021).","DOI":"10.3390\/cancers13215274"},{"key":"12761_CR49","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s11481-011-9337-9","volume":"7","author":"SL Chen","year":"2012","unstructured":"Chen, S. L. et al. Low-dose memantine attenuated morphine addictive behavior through its anti-inflammation and neurotrophic effects in rats. J. Neuroimmune Pharmacol. 7, 444\u2013453. https:\/\/doi.org\/10.1007\/s11481-011-9337-9 (2012).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"12761_CR50","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/1570193x113106660031","volume":"10","author":"J Skrabalova","year":"2013","unstructured":"Skrabalova, J., Drastichova, Z. & Novotny, J. Morphine as a potential oxidative stress-causing agent. Mini Rev. Org. Chem. 10, 367\u2013372. https:\/\/doi.org\/10.2174\/1570193x113106660031 (2013).","journal-title":"Mini Rev. Org. Chem."},{"key":"12761_CR51","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1590\/2175-8239-JBN-2022-0180en","volume":"46","author":"S Cavdar","year":"2024","unstructured":"Cavdar, S. et al. Effect of octreotide on oxidative stress in the erythrocyte and kidney tissue in adriamycin-induced experimental nephrotic syndrome model. J. Bras. Nefrol. 46, 18\u201328. https:\/\/doi.org\/10.1590\/2175-8239-JBN-2022-0180en (2024).","journal-title":"J. Bras. Nefrol"},{"key":"12761_CR52","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0006-8993(01)02063-7","volume":"895","author":"M Gotoh","year":"2001","unstructured":"Gotoh, M., Iguchi, A., Kakumu, S., Hirooka, Y. & Smythe, G. A. Central suppressive effect of octreotide on the hyperglycemic response to 2-deoxy-d-glucose injection or cold-swim stress in awake rats: possible mediation role of hypothalamic noradrenergic drive. Brain Res. 895, 146\u2013152 (2001).","journal-title":"Brain Res."},{"key":"12761_CR53","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/00004647-199707000-00001","volume":"17","author":"WM Pardridge","year":"1997","unstructured":"Pardridge, W. M. Drug delivery to the brain. J. Cereb. Blood Flow. Metab. 17, 713\u2013731. https:\/\/doi.org\/10.1097\/00004647-199707000-00001 (1997).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"12761_CR54","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/10611860400000938","volume":"12","author":"EN Lerner","year":"2004","unstructured":"Lerner, E. N., van Zanten, E. H. & Stewart, G. R. Enhanced delivery of octreotide to the brain via transnasal iontophoretic administration. J. Drug Target. 12, 273\u2013280. https:\/\/doi.org\/10.1080\/10611860400000938 (2004).","journal-title":"J. Drug Target."},{"key":"12761_CR55","doi-asserted-by":"publisher","first-page":"22410","DOI":"10.1002\/dev.22410","volume":"65","author":"A Hassanshahi","year":"2023","unstructured":"Hassanshahi, A. et al. Preventive putative effect of Agmatine on cognitive and molecular outcomes in ventral tegmental area of male offspring following physical and psychological prenatal stress. Dev. Psychobiol. 65, 22410 (2023).","journal-title":"Dev. Psychobiol."},{"key":"12761_CR56","doi-asserted-by":"crossref","unstructured":"Saffarpour, S. et al. The alteration of hippocampal BDNF expression is associated with anxiety-like behavior following the injury to the sciatic nerve. Arch. Neurosci. 6 (2019).","DOI":"10.5812\/ans.74029"},{"key":"12761_CR57","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1177\/0748233714525497","volume":"32","author":"M Razavinasab","year":"2016","unstructured":"Razavinasab, M., Moazzami, K. & Shabani, M. Maternal mobile phone exposure alters intrinsic electrophysiological properties of CA1 pyramidal neurons in rat offspring. Toxicol. Ind. Health. 32, 968\u2013979. https:\/\/doi.org\/10.1177\/0748233714525497 (2016).","journal-title":"Toxicol. Ind. Health"},{"key":"12761_CR58","doi-asserted-by":"crossref","unstructured":"Hassanshahi, A. et al. Administration of Agmatine prior to physical or psychological stress in pregnant mice ameliorates behavioural and cognitive deficits in female offspring. Int. J. Dev. Neurosci. (2023).","DOI":"10.1002\/jdn.10277"},{"key":"12761_CR59","doi-asserted-by":"publisher","first-page":"e02139","DOI":"10.1002\/brb3.2139","volume":"11","author":"M Khaleghi","year":"2021","unstructured":"Khaleghi, M. et al. Estrogen attenuates physical and psychological stress-induced cognitive impairments in ovariectomized rats. Brain Behav. 11, e02139. https:\/\/doi.org\/10.1002\/brb3.2139 (2021).","journal-title":"Brain Behav."},{"key":"12761_CR60","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.1038\/s41598-023-33016-2","volume":"13","author":"M Shabani","year":"2023","unstructured":"Shabani, M., Ilaghi, M., Naderi, R. & Razavinasab, M. The hyperexcitability of laterodorsal tegmentum cholinergic neurons accompanies adverse behavioral and cognitive outcomes of prenatal stress. Sci. Rep. 13, 6011. https:\/\/doi.org\/10.1038\/s41598-023-33016-2 (2023).","journal-title":"Sci. Rep."},{"key":"12761_CR61","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/jdn.10161","volume":"82","author":"M Razavinasab","year":"2022","unstructured":"Razavinasab, M. et al. Early environmental enrichment prevents cognitive impairments and developing addictive behaviours in a mouse model of prenatal psychological and physical stress. Int. J. Dev. Neurosci. 82, 72\u201384. https:\/\/doi.org\/10.1002\/jdn.10161 (2022).","journal-title":"Int. J. Dev. Neurosci."},{"key":"12761_CR62","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/0306-4522(95)00409-2","volume":"70","author":"JL Giacchino","year":"1996","unstructured":"Giacchino, J. L. & Henriksen, S. J. Systemic morphine and local opioid effects on neuronal activity in the medial prefrontal cortex. Neuroscience. 70, 941\u2013949. https:\/\/doi.org\/10.1016\/0306-4522(95)00409-2 (1996).","journal-title":"Neuroscience"},{"key":"12761_CR63","doi-asserted-by":"publisher","first-page":"21460","DOI":"10.1038\/s41598-023-46427-y","volume":"13","author":"EO Ayieng\u2019a","year":"2023","unstructured":"Ayieng\u2019a, E. O. et al. Morphine aggravates inflammatory, behavioral, and hippocampal structural deficits in septic rats. Sci. Rep. 13, 21460. https:\/\/doi.org\/10.1038\/s41598-023-46427-y (2023).","journal-title":"Sci. Rep."},{"key":"12761_CR64","doi-asserted-by":"publisher","first-page":"9864","DOI":"10.1038\/s41598-024-60518-4","volume":"14","author":"Z Pirmoradi","year":"2024","unstructured":"Pirmoradi, Z. et al. Resveratrol and 1,25-dihydroxyvitamin D decrease Lingo-1 levels, and improve behavior in harmaline-induced essential tremor, suggesting potential therapeutic benefits. Sci. Rep. 14, 9864. https:\/\/doi.org\/10.1038\/s41598-024-60518-4 (2024).","journal-title":"Sci. Rep."},{"key":"12761_CR65","unstructured":"Release, S. (2021)."},{"key":"12761_CR66","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10822-010-9349-1","volume":"24","author":"JR Greenwood","year":"2010","unstructured":"Greenwood, J. R., Calkins, D., Sullivan, A. P. & Shelley, J. C. Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric States of drug-like molecules in aqueous solution. J. Comput. Aided Mol. Des. 24, 591\u2013604 (2010).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"12761_CR67","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","volume":"17","author":"C Lu","year":"2021","unstructured":"Lu, C. et al. Improving force field accuracy on challenging regimes of chemical space. J. Chem. Theory Comput. 17, 4291\u20134300 (2021).","journal-title":"J. Chem. Theory Comput"},{"key":"12761_CR68","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R. & Sherman, W. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J. Comput. Aided Mol. Des. 27, 221\u2013234 (2013).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"12761_CR69","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0022-2836(02)00470-9","volume":"320","author":"MP Jacobson","year":"2002","unstructured":"Jacobson, M. P., Friesner, R. A., Xiang, Z. & Honig, B. On the role of the crystal environment in determining protein side-chain conformations. J. Mol. Biol. 320, 597\u2013608 (2002).","journal-title":"J. Mol. Biol."},{"key":"12761_CR70","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/prot.10613","volume":"55","author":"MP Jacobson","year":"2004","unstructured":"Jacobson, M. P. et al. A hierarchical approach to all-atom protein loop prediction. Proteins Struct. Funct. Bioinform. 55, 351\u2013367 (2004).","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"12761_CR71","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren, T. A. et al. Glide: a new approach for rapid, accurate Docking and scoring. 2. Enrichment factors in database screening. J. Med. Chem. 47, 1750\u20131759 (2004).","journal-title":"J. Med. Chem."},{"key":"12761_CR72","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner, R. A. et al. Glide: a new approach for rapid, accurate Docking and scoring. 1. Method and assessment of Docking accuracy. J. Med. Chem. 47, 1739\u20131749 (2004).","journal-title":"J. Med. Chem."},{"key":"12761_CR73","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner, R. A. et al. Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein\u2009\u2013\u2009ligand complexes. J. Med. Chem. 49, 6177\u20136196 (2006).","journal-title":"J. Med. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12761-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12761-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12761-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T22:54:57Z","timestamp":1757458497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12761-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12761"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12761-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"24 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experiments were done in accordance with the ARRIVE guidelines and National Institutes of Health Guide for the Care and Use of Laboratory Animals) NIH Publication No. 80-23, revised 1996). All experiments were performed in accordance with the protocols approved by Kerman University of Medical Sciences Laboratory Animal Care and was accepted by the Institutional Review Board (IRB) of Kerman University of Medical Sciences (IRB code: IR.KMU.REC.1400.242).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"29853"}}